87 related articles for article (PubMed ID: 7504956)
1. Efficient generation of human anti-cytomegalovirus IgG monoclonal antibodies from preselected antigen-specific B cells.
Steenbakkers PG; Van Wezenbeek PM; van Zanten J; The TH
Hum Antibodies Hybridomas; 1993 Oct; 4(4):166-73. PubMed ID: 7504956
[TBL] [Abstract][Full Text] [Related]
2. [Human monoclonal anti-cytomegalovirus antibodies].
Seigneurin JM; Desgranges C
Ann Med Interne (Paris); 1987; 138(5):343-6. PubMed ID: 2823659
[TBL] [Abstract][Full Text] [Related]
3. A human monoclonal antibody to cytomegalovirus (CMV).
Emanuel D; Gold J; Colacino J; Lopez C; Hammerling U
J Immunol; 1984 Oct; 133(4):2202-5. PubMed ID: 6088634
[TBL] [Abstract][Full Text] [Related]
4. Characterization of human monoclonal antibodies directed against the pp65-kD matrix antigen of human cytomegalovirus.
Ohlin M; Sundqvist VA; Gilljam G; Rudén U; Gombert FO; Wahren B; Borrebaeck CA
Clin Exp Immunol; 1991 Jun; 84(3):508-14. PubMed ID: 1710548
[TBL] [Abstract][Full Text] [Related]
5. Human monoclonal antibodies recognize early and late viral proteins of human cytomegalovirus.
Alexander H; Harpprecht J; Podzuweit HG; Rautenberg P; Müller-Ruchholtz W
Hum Antibodies Hybridomas; 1994; 5(1-2):81-90. PubMed ID: 7858186
[TBL] [Abstract][Full Text] [Related]
6. Human monoclonal antibodies to a genus-specific chlamydial antigen, produced by EBV-transformed B cells.
Rosén A; Persson K; Klein G
J Immunol; 1983 Jun; 130(6):2899-902. PubMed ID: 6189902
[TBL] [Abstract][Full Text] [Related]
7. IgG subclass antibodies to human cytomegalovirus (CMV) in normal human plasma samples and immune globulins and their neutralizing activities.
Gupta CK; Leszczynski J; Gupta RK; Siber GR
Biologicals; 1996 Jun; 24(2):117-24. PubMed ID: 8889058
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.
Keever-Taylor CA; Margolis D; Konings S; Sandford GR; Nicolette CA; Lawendowski C; Burns WH
Biol Blood Marrow Transplant; 2001; 7(5):247-56. PubMed ID: 11400946
[TBL] [Abstract][Full Text] [Related]
9. Identification of cytomegalovirus (CMV)pp65 antigen-specific human monoclonal antibodies using single B cell-based antibody gene cloning from melanoma patients.
Iizuka A; Komiyama M; Tai S; Oshita C; Kurusu A; Kume A; Ozawa K; Nakamura Y; Ashizawa T; Yamamoto A; Yamazaki N; Yoshikawa S; Kiyohara Y; Yamaguchi K; Akiyama Y
Immunol Lett; 2011 Mar; 135(1-2):64-73. PubMed ID: 20932861
[TBL] [Abstract][Full Text] [Related]
10. Human monoclonal antibodies to cytomegalovirus recognize viral epitopes on the surface of virus-infected cells.
Larose Y; Tackaberry ES; Brodeur BR
Hum Antibodies Hybridomas; 1991 Apr; 2(2):67-73. PubMed ID: 1714785
[TBL] [Abstract][Full Text] [Related]
11. An enzyme immunoassay based micro-neutralization test for titration of antibodies to human cytomegalovirus (CMV) and its correlation with direct ELISA measuring CMV IgG antibodies.
Gupta CK; Leszczynski J; Gupta RK; Siber GR
Biologicals; 1996 Mar; 24(1):41-9. PubMed ID: 8733600
[TBL] [Abstract][Full Text] [Related]
12. [Production of monoclonal antibodies against human cytomegalovirus].
Mazeron MC; Berbar T; Guillemin MC; Colimon R; Roseto A; Perol Y
C R Seances Acad Sci III; 1983; 297(6):305-8. PubMed ID: 6318932
[TBL] [Abstract][Full Text] [Related]
13. Human monoclonal antibodies to human cytomegalovirus derived from peripheral blood lymphocytes of healthy adults.
Kitamura K; Yamada K; Kuzushima K; Morishima T; Morishima Y; Yamamoto N; Nishiyama Y; Ohya K; Yamaguchi H
J Med Virol; 1990 Sep; 32(1):60-6. PubMed ID: 2173739
[TBL] [Abstract][Full Text] [Related]
14. Human anti-cytomegalovirus (CMV) immunoglobulins secreted by EBV-transformed B-lymphocytes cell lines.
Amadei C; Michelson S; Frot JC; Fruchart MF; Nicolas H; Boué A
Dev Biol Stand; 1984; 57():283-6. PubMed ID: 6098499
[TBL] [Abstract][Full Text] [Related]
15. In vitro stimulation of human peripheral blood B cells from normal individuals by activated T cells increases the efficiency of hybridoma generation.
Ferraro AS; Newkirk MM
Hum Antibodies Hybridomas; 1993 Apr; 4(2):80-5. PubMed ID: 8100151
[TBL] [Abstract][Full Text] [Related]
16. Prevention of CMV-induced myelosuppression by anti-CMV antibodies: an in vitro model.
Bron D; Lagneaux L; Delforge A; Otte C; Snoeck R; Stryckmans P
Exp Hematol; 1991 Feb; 19(2):132-5. PubMed ID: 1846820
[TBL] [Abstract][Full Text] [Related]
17. Production of human monoclonal IgG antibodies reacting with cytomegalovirus (CMV).
Bron D; Delforge A; Lagneaux L; De Martynoff G; Bosmans E; Van der Auwera P; Snoeck R; Burny A; Stryckmans P
J Immunol Methods; 1990 Jul; 130(2):209-16. PubMed ID: 2165098
[TBL] [Abstract][Full Text] [Related]
18. Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies.
Chaushu G; Chaushu S; Slavin S; Or R; Garfunkel AA; Yefenof E
Bone Marrow Transplant; 1996 Feb; 17(2):237-41. PubMed ID: 8640173
[TBL] [Abstract][Full Text] [Related]
19. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal anti-parasite and anti-RBC antibodies produced by stable EBV-transformed B cell lines from malaria patients.
Lundgren K; Wahlgren M; Troye-Blomberg M; Berzins K; Perlmann H; Perlmann P
J Immunol; 1983 Oct; 131(4):2000-3. PubMed ID: 6311902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
